External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home IGCS 2023
Roche and Genentech at

IGCS 2023

November 05 - November 07
Seoul, Korea
igcs.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
12:18 AM
Duration 90mins Auditorium
Watch Efficacy and safety results from SKYSCRAPER-04: An open-label randomized phase 2 trial of tiragolumab plus atezolizumab for PD-L1-positive recurrent cervical cancer
Ritu Salani
Oncology | Cervical Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.